COST-EFFECTIVENESS ANALYSIS OF REGORAFENIB IN GASTROINTESTINAL STROMAL TUMOURS IN ENGLAND USING CROSSOVER ADJUSTMENT METHODS

被引：0
|
作者：
Pitcher, A. [1 ]
Grabbi, E. [2 ]
Madin-Warburton, M. [1 ]
Vadgama, S. [1 ]
机构：
[1] IMS Hlth, London, England
[2] Bayer Pharmaceut, Newbury, Berks, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.2255
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN182
引用
收藏
页码：A741 / A741
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness analysis: Methods and applications
    Plank, DN
    COMPARATIVE EDUCATION REVIEW, 2002, 46 (01) : 141 - 143
  • [22] Cost-Effectiveness Analysis of Pharmacotherapy of Adjustment Disorder in Youth
    Dimitrijevic, Radmila Ristic
    Dimitrijevic, Snezana
    Lazic, Dijana
    Nenadovic, Milutin
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2013, 16 : S29 - S29
  • [23] A decision analysis comparing the cost-effectiveness of pantoprazole in England
    Culshaw, K
    Vierqutz, S
    Edwards, AM
    Schlander, M
    GUT, 1997, 41 : A97 - A98
  • [24] Cost-effectiveness of three years of adjuvant imatinib in gastrointestinal stromal tumors (GIST).
    Sanon, Myrlene
    Parthan, Anju
    Taylor, Douglas
    Coombs, John
    Paolantonio, Marc
    Sasane, Medha
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [25] COST-EFFECTIVENESS ANALYSIS OF EMMUNONUTRITION FOR GASTROINTESTINAL CANCER PATIENTS
    Chevrou-Severac, H.
    Pinget, C.
    Wasserfallen, J-B
    Demartines, N.
    Ochoa, J. B.
    INTENSIVE CARE MEDICINE, 2011, 37 : S35 - S35
  • [26] Cost-Effectiveness Analysis of Fourth- or Further-Line Ripretinib in Advanced Gastrointestinal Stromal Tumors
    Liao, Weiting
    Xu, Huiqiong
    Hutton, David
    Wu, Qiuji
    Zhou, Kexun
    Luo, Hui
    Lei, Wanting
    Feng, Mingyang
    Yang, Yang
    Wen, Feng
    Li, Qiu
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] COST-EFFECTIVENESS ANALYSIS OF REGORAFENIB USED IN CHINESE PATIENTS WITH METASTATIC COLORECTAL CANCER
    Zhang, S.
    Ma, A. X.
    Li, H.
    Rascati, K.
    VALUE IN HEALTH, 2020, 23 : S43 - S43
  • [28] Cost-effectiveness analysis methods for the REACT study
    Duren-Winfield, V
    Berry, MJ
    Jones, SA
    Clark, DH
    Sevick, MA
    WESTERN JOURNAL OF NURSING RESEARCH, 2000, 22 (04) : 460 - 474
  • [29] Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data
    Willan, AR
    Briggs, AH
    Hoch, JS
    HEALTH ECONOMICS, 2004, 13 (05) : 461 - 475
  • [30] USING METAMODELING TO APPROXIMATE COST-EFFECTIVENESS ACCEPTABILITY CURVES OF COST-EFFECTIVENESS ANALYSIS
    Xie, Jingyi
    Chen, Qiushi
    MEDICAL DECISION MAKING, 2020, 40 (01) : E362 - E364
12345